HomeAPS • FRA
add
Asarina Pharma AB (publ)
Previous close
€0.042
Year range
€0.039 - €0.096
Market cap
155.57M EUR
Avg Volume
1.00
P/E ratio
0.81
Dividend yield
54.62%
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.56M | -23.43% |
Net income | -1.67M | 34.33% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.46M | 24.14% |
Effective tax rate | 34.38% | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.16M | -76.72% |
Total assets | 6.08M | -63.95% |
Total liabilities | 4.43M | 96.45% |
Total equity | 1.65M | — |
Shares outstanding | 22.64M | — |
Price to book | 0.61 | — |
Return on assets | -105.21% | — |
Return on capital | -241.36% | — |
Cash Flow
Net change in cash
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.67M | 34.33% |
Cash from operations | -1.10M | -348.81% |
Cash from investing | — | — |
Cash from financing | 500.00K | 2,600.00% |
Net change in cash | -784.00K | -223.08% |
Free cash flow | -1.50M | 26.54% |
About
Founded
2005
Website
Employees
6